Browsing by Author "Lum, Emily"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    A Telehealth-Based Randomized Controlled Trial: A Model for Outpatients Trials of Off-Label Medications During the COVID-19 Pandemic
    (Sage, 2021-08) Keyhani, Salomeh; Kelly, J. Daniel; Bent, Stephen; Boscardin, W. John; Shlipak, Michael G.; Leonard, Sam; Abraham, Ann; Lum, Emily; Lau, Nicholas; Austin, Charles; Oldenburg, Catherine E.; Zillich, Allan; Lopez, Lenny; Zhang, Ying; Lietman, Tom; Bravata, Dawn M.; Medicine, School of Medicine
    The study was registered at clinicaltrials.gov: NCT04363203
  • Thumbnail Image
    Item
    The Heart and Cannabis (THC) Cohort: Differences in Baseline Health and Behaviors by Cannabis Use
    (Springer, 2022) Keyhani, Salomeh; Cohen, Beth E.; Vali, Marzieh; Hoggatt, Katherine J.; Bravata, Dawn M.; Austin, Peter C.; Lum, Emily; Hasin, Deborah S.; Grunfeld, Carl; Shlipak, Michael G.; Medicine, School of Medicine
    Background: Evidence on the cardiovascular health effects of cannabis use is limited. We designed a prospective cohort study of older Veterans (66 to 68 years) with coronary artery disease (CAD) to understand the cardiovascular consequences of cannabis use. We describe the cohort construction, baseline characteristics, and health behaviors that were associated with smoking cannabis. Objective: To understand the cardiovascular consequences of cannabis use. Design: We designed a prospective cohort study of older Veterans (66 to 68 years) with CAD. Participants: A total of 1,015 current cannabis smokers and 3,270 non-cannabis smokers with CAD. Main measures: Using logistic regression, we examined the association of baseline variables with smoking cannabis in the past 30 days. Results: The current cannabis smokers and non-current smokers were predominantly male (97.2% vs 97.1%, p=0.96). Characteristics associated with recent cannabis use in multivariable analyses included lack of a high school education (odds ratio [OR] 2.15, 95% confidence interval [CI]: 1.10 to 4.19), financial difficulty (OR 1.47, 95% CI: 1.02 to 2.11), tobacco use (OR 3.02, 95% CI: 1.66 to 5.48), current drug use (OR 2.82, 95% CI: 1.06 to 7.46), and prior drug use (OR 2.84, 95% CI: 2.11 to 3.82). In contrast, compared to individuals with 0 to 1 comorbid conditions, those with 5 chronic conditions or more (OR 0.43, 95% CI: 0.27 to 0.70) were less likely to smoke cannabis. Conclusions: In this older high-risk cohort, smoking cannabis was associated with higher social and behavioral risk, but with fewer chronic health conditions.